Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Long Lag Between Drug-induced Parkinsonism and Idiopathic Parkinson's Disease in Idiopathic REM Sleep Behavior Disorder.

Fereshtehnejad SM, Dawson BK, Pelletier A, Montplaisir JY, Postuma RB.

Mov Disord Clin Pract. 2018 Jan 10;5(2):203-205. doi: 10.1002/mdc3.12576. eCollection 2018 Mar-Apr. No abstract available.

2.

Reliability and Validity of Fall Efficacy Scale-International in People with Parkinson's Disease during On- and Off-Drug Phases.

Mehdizadeh M, Martinez-Martin P, Habibi SA, Fereshtehnejad SM, Abasi A, Niazi Khatoon J, Saneii SH, Taghizadeh G.

Parkinsons Dis. 2019 Jan 2;2019:6505232. doi: 10.1155/2019/6505232. eCollection 2019.

3.

The Burden of Road Traffic Injuries in Iran and 15 Surrounding Countries: 1990-2016.

Bazargan-Hejazi S, Ahmadi A, Shirazi A, Ainy E, Djalalinia S, Fereshtehnejad SM, Jahanmehr N, Kiadaliri A, Moradi-Lakeh M, Parsaeian M, Pourmalek F, Rahimi K, Sepanlou SG, Tehrani A, Malekzadeh R, Naghavi M.

Arch Iran Med. 2018 Dec 1;21(12):556-565.

4.

Risk factors for possible REM sleep behavior disorder: A CLSA population-based cohort study.

Yao C, Fereshtehnejad SM, Keezer MR, Wolfson C, Pelletier A, Postuma RB.

Neurology. 2018 Dec 26. pii: 10.1212/WNL.0000000000006849. doi: 10.1212/WNL.0000000000006849. [Epub ahead of print]

PMID:
30587514
5.

Mediating Effect of Mutuality on Health-Related Quality of Life in Patients with Parkinson's Disease.

Karlstedt M, Fereshtehnejad SM, Aarsland D, Lökk J.

Parkinsons Dis. 2018 Sep 16;2018:9548681. doi: 10.1155/2018/9548681. eCollection 2018.

6.

High burden of neurological disease in the older general population: results from the Canadian Longitudinal Study on Aging.

Wolfson C, Fereshtehnejad SM, Pasquet R, Postuma R, Keezer MR.

Eur J Neurol. 2019 Feb;26(2):356-362. doi: 10.1111/ene.13823. Epub 2018 Oct 31.

PMID:
30300458
7.

White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.

Dadar M, Zeighami Y, Yau Y, Fereshtehnejad SM, Maranzano J, Postuma RB, Dagher A, Collins DL.

Neuroimage Clin. 2018;20:892-900. doi: 10.1016/j.nicl.2018.09.025. Epub 2018 Sep 27.

8.

Psychometric properties of the Berg balance scale in idiopathic Parkinson' disease in the drug off-phase.

Taghizadeh G, Martinez-Martin P, Fereshtehnejad SM, Habibi SA, Nikbakht N, Alizadeh NH, Salehi S, Mehdizadeh M.

Neurol Sci. 2018 Dec;39(12):2175-2181. doi: 10.1007/s10072-018-3570-4. Epub 2018 Sep 22.

PMID:
30244299
9.

Answer to a Commentary on "Tango for treatment of motor and non-motor manifestations in Parkinson's disease: A randomized control study".

Rios Romenets S, Fereshtehnejad SM, Postuma R.

Complement Ther Med. 2018 Oct;40:258-259. doi: 10.1016/j.ctim.2017.11.005. Epub 2017 Nov 20. No abstract available.

PMID:
30219464
10.
11.

Autonomic Sweat Responses in REM Sleep Behavior Disorder and Parkinsonism.

Al-Qassabi A, Pelletier A, Fereshtehnejad SM, Postuma RB.

J Parkinsons Dis. 2018;8(3):463-468. doi: 10.3233/JPD-181357.

PMID:
30040743
12.

Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable?

Yao C, Fereshtehnejad SM, Dawson BK, Pelletier A, Gan-Or Z, Gagnon JF, Montplaisir JY, Postuma RB.

Parkinsonism Relat Disord. 2018 Sep;54:99-102. doi: 10.1016/j.parkreldis.2018.04.010. Epub 2018 Apr 4.

PMID:
29724601
13.

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts.

Dawson BK, Fereshtehnejad SM, Anang JBM, Nomura T, Rios-Romenets S, Nakashima K, Gagnon JF, Postuma RB.

JAMA Neurol. 2018 Jun 1;75(6):704-710. doi: 10.1001/jamaneurol.2018.0254.

PMID:
29582054
14.

A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging.

Zeighami Y, Fereshtehnejad SM, Dadar M, Collins DL, Postuma RB, Mišić B, Dagher A.

Neuroimage. 2017 Dec 19. pii: S1053-8119(17)31074-1. doi: 10.1016/j.neuroimage.2017.12.050. [Epub ahead of print] Review.

PMID:
29277406
15.

A Mitochondrial Disorder in a Middle Age Iranian Patient: Report of a Rare Case.

Almasi M, Motamed MR, Mehrpour M, Haghi-Ashtiani B, Haji Akhondi F, Nilipour Y, Fereshtehnejad SM.

Basic Clin Neurosci. 2017 Jul-Aug;8(4):337-341. doi: 10.18869/nirp.bcn.8.4.337.

16.

Multiple sclerosis and environmental risk factors: a case-control study in Iran.

Abbasi M, Nabavi SM, Fereshtehnejad SM, Jou NZ, Ansari I, Shayegannejad V, Mohammadianinejad SE, Farhoudi M, Noorian A, Razazian N, Abedini M, Faraji F.

Neurol Sci. 2017 Nov;38(11):1941-1951. doi: 10.1007/s10072-017-3080-9. Epub 2017 Aug 10.

PMID:
28799006
17.

Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson's Disease: Longitudinal Data from the Jönköping Parkinson Registry.

Fereshtehnejad SM, Skogar Ö, Lökk J.

Parkinsons Dis. 2017;2017:7802819. doi: 10.1155/2017/7802819. Epub 2017 Jul 16.

18.

Burden of Skin and Subcutaneous Diseases in Iran and Neighboring Countries: Results from the Global Burden of Disease Study 2015.

Karimkhani C, Dellavalle RP, Karimi SM, Rahimi-Movaghar V, Pourmalek F, Kiadaliri AA, Sahraian MA, Roshandel G, Fereshtehnejad SM, Qorbani M, Radfar A, Farvid MS, Asayesh H, Sepanlou SG, Djalalinia S, Kasaeian A, Khubchandani J, Malekzadeh R, Moradi-Lakeh M, Krohn KJ, Mokdad AH, Vos T, Naghavi M.

Arch Iran Med. 2017 Jul;20(7):429-440.

19.

Trend of Socio-Demographic Index and Mortality Estimates in Iran and its Neighbors, 1990-2015; Findings of the Global Burden of Diseases 2015 Study.

Moradi-Lakeh M, Sepanlou SG, Karimi SM, Khalili N, Djalalinia S, Karimkhani C, Krohn K, Afshin A, Farzadfar F, Kiadaliri AA, Asadi-Lari M, Asayesh H, Esteghamati AR, Farvid MS, Fereshtehnejad SM, Heydarpour P, Khosravi A, Khubchandani J, Kasaeian A, Rana SM, Mahdavi M, Masoudifarid H, Mohammadi A, Pourmalek F, Qorbani M, Radfar A, Rahimi K, Rahimi-Movaghar V, Roshandel G, Safi S, Salamati P, Tehrani-Banihashemi A, Bazargan-Hejazi S, Vos T, Malekzadeh R, Mokdad AH, Murray CJL, Naghavi M.

Arch Iran Med. 2017 Jul;20(7):419-428.

20.

Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.

Sepanlou SG, Parsaeian M, Krohn KJ, Afshin A, Farzadfar F, Roshandel G, Karimkhani C, Bazargan-Hejazi S, Kiadaliri AA, Ahmadieh H, Djalalinia S, Ebrahimi H, Eshrati B, Esteghamati AR, Farvid MS, Fereshtehnejad SM, Hafezi-Nejad N, Hassanvand MS, Heydarpour P, Islami F, Karimi SM, Katibeh M, Khosravi A, Khubchandani J, Mahdavi M, Pishgar F, Qorbani M, Rahimi-Movaghar V, Safi S, Sahraian MA, Shahraz S, Sheikhbahaei S, Mohammadi A, Mokdad AH, Vos T, Murray CJL, Moradi-Lakeh M, Naghavi M, Malekzadeh R.

Arch Iran Med. 2017 Jul;20(7):403-418.

21.

Prevalence and Years Lived with Disability of 310 Diseases and Injuries in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.

Djalalinia S, Saeedi Moghaddam S, Moradi-Lakeh M, Shahraz S, Naghavi M, Murray CJL, Vos T, Mokhdad AH, Krohn K, Danaei G, Afshin A, Sepanlou SG, Bazargan-Hejazi S, Peykari N, Rezaei N, Roshandel G, Karimkhani C, Moazen B, Pourmalek F, Esteghamati AR, Hafezi-Nejad N, Sheikhbahaei S, Katibeh M, Ahmadieh H, Safi S, Qorbani M, Islami F, Khosravi A, Hasanvand MS, Mahdavi M, Kiadaliri AA, Farvid MS, Karimi SM, Mohammadi A, Asayesh H, Assadi R, Khubchandani J, Heydarpour P, Fereshtehnejad SM, Safiri S, Kasaeian A, Larijani B, Malekzadeh R, Farzadfar F.

Arch Iran Med. 2017 Jul;20(7):392-402.

22.

Dental care utilization in patients with different types of dementia: A longitudinal nationwide study of 58,037 individuals.

Fereshtehnejad SM, Garcia-Ptacek S, Religa D, Holmer J, Buhlin K, Eriksdotter M, Sandborgh-Englund G.

Alzheimers Dement. 2018 Jan;14(1):10-19. doi: 10.1016/j.jalz.2017.05.004. Epub 2017 Jul 8.

23.

Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry.

Secnik J, Cermakova P, Fereshtehnejad SM, Dannberg P, Johnell K, Fastbom J, Winblad B, Eriksdotter M, Religa D.

Diabetes Care. 2017 Sep;40(9):1159-1166. doi: 10.2337/dc16-2516. Epub 2017 Jun 27.

24.

Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.

Shafieesabet A, Fereshtehnejad SM, Shafieesabet A, Delbari A, Baradaran HR, Postuma RB, Lökk J.

Parkinsonism Relat Disord. 2017 Sep;42:1-11. doi: 10.1016/j.parkreldis.2017.06.006. Epub 2017 Jun 15. Review.

PMID:
28647434
25.

Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.

Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB.

Brain. 2017 Jul 1;140(7):1959-1976. doi: 10.1093/brain/awx118.

PMID:
28549077
26.

Sleep Disturbances in the Prodromal Stage of Parkinson Disease.

Al-Qassabi A, Fereshtehnejad SM, Postuma RB.

Curr Treat Options Neurol. 2017 Jun;19(6):22. doi: 10.1007/s11940-017-0458-1. Review.

PMID:
28466429
27.

Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.

Fereshtehnejad SM, Montplaisir JY, Pelletier A, Gagnon JF, Berg D, Postuma RB.

Mov Disord. 2017 Jun;32(6):865-873. doi: 10.1002/mds.26989. Epub 2017 Apr 21.

PMID:
28429825
28.

Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?

Fereshtehnejad SM, Postuma RB.

Curr Neurol Neurosci Rep. 2017 Apr;17(4):34. doi: 10.1007/s11910-017-0738-x. Review.

PMID:
28324303
29.

Determinants of Dyadic Relationship and Its Psychosocial Impact in Patients with Parkinson's Disease and Their Spouses.

Karlstedt M, Fereshtehnejad SM, Aarsland D, Lökk J.

Parkinsons Dis. 2017;2017:4697052. doi: 10.1155/2017/4697052. Epub 2017 Feb 14.

30.

Prevalence and associated comorbidities of restless legs syndrome (RLS): Data from a large population-based door-to-door survey on 19176 adults in Tehran, Iran.

Fereshtehnejad SM, Rahmani A, Shafieesabet M, Soori M, Delbari A, Motamed MR, Lökk J.

PLoS One. 2017 Feb 17;12(2):e0172593. doi: 10.1371/journal.pone.0172593. eCollection 2017.

31.

Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013.

Moradi-Lakeh M, Forouzanfar MH, Vollset SE, El Bcheraoui C, Daoud F, Afshin A, Charara R, Khalil I, Higashi H, Abd El Razek MM, Kiadaliri AA, Alam K, Akseer N, Al-Hamad N, Ali R, AlMazroa MA, Alomari MA, Al-Rabeeah AA, Alsharif U, Altirkawi KA, Atique S, Badawi A, Barrero LH, Basulaiman M, Bazargan-Hejazi S, Bedi N, Bensenor IM, Buchbinder R, Danawi H, Dharmaratne SD, Zannad F, Farvid MS, Fereshtehnejad SM, Farzadfar F, Fischer F, Gupta R, Hamadeh RR, Hamidi S, Horino M, Hoy DG, Hsairi M, Husseini A, Javanbakht M, Jonas JB, Kasaeian A, Khan EA, Khubchandani J, Knudsen AK, Kopec JA, Lunevicius R, Abd El Razek HM, Majeed A, Malekzadeh R, Mate K, Mehari A, Meltzer M, Memish ZA, Mirarefin M, Mohammed S, Naheed A, Obermeyer CM, Oh IH, Park EK, Peprah EK, Pourmalek F, Qorbani M, Rafay A, Rahimi-Movaghar V, Shiri R, Rahman SU, Rai RK, Rana SM, Sepanlou SG, Shaikh MA, Shiue I, Sibai AM, Silva DAS, Singh JA, Skogen JC, Terkawi AS, Ukwaja KN, Westerman R, Yonemoto N, Yoon SJ, Younis MZ, Zaidi Z, Zaki MES, Lim SS, Wang H, Vos T, Naghavi M, Lopez AD, Murray CJL, Mokdad AH.

Ann Rheum Dis. 2017 Aug;76(8):1365-1373. doi: 10.1136/annrheumdis-2016-210146. Epub 2017 Feb 16.

32.

Sexual dimorphism in Parkinson's disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females.

Farhadi F, Vosoughi K, Shahidi GA, Delbari A, Lökk J, Fereshtehnejad SM.

Neuropsychiatr Dis Treat. 2017 Feb 1;13:329-338. doi: 10.2147/NDT.S124984. eCollection 2017.

33.

The Burden of Mental Disorders in the Eastern Mediterranean Region, 1990-2013.

Charara R, Forouzanfar M, Naghavi M, Moradi-Lakeh M, Afshin A, Vos T, Daoud F, Wang H, El Bcheraoui C, Khalil I, Hamadeh RR, Khosravi A, Rahimi-Movaghar V, Khader Y, Al-Hamad N, Makhlouf Obermeyer C, Rafay A, Asghar R, Rana SM, Shaheen A, Abu-Rmeileh NM, Husseini A, Abu-Raddad LJ, Khoja T, Al Rayess ZA, AlBuhairan FS, Hsairi M, Alomari MA, Ali R, Roshandel G, Terkawi AS, Hamidi S, Refaat AH, Westerman R, Kiadaliri AA, Akanda AS, Ali SD, Bacha U, Badawi A, Bazargan-Hejazi S, Faghmous IA, Fereshtehnejad SM, Fischer F, Jonas JB, Kuate Defo B, Mehari A, Omer SB, Pourmalek F, Uthman OA, Mokdad AA, Maalouf FT, Abd-Allah F, Akseer N, Arya D, Borschmann R, Brazinova A, Brugha TS, Catalá-López F, Degenhardt L, Ferrari A, Haro JM, Horino M, Hornberger JC, Huang H, Kieling C, Kim D, Kim Y, Knudsen AK, Mitchell PB, Patton G, Sagar R, Satpathy M, Savuon K, Seedat S, Shiue I, Skogen JC, Stein DJ, Tabb KM, Whiteford HA, Yip P, Yonemoto N, Murray CJ, Mokdad AH.

PLoS One. 2017 Jan 17;12(1):e0169575. doi: 10.1371/journal.pone.0169575. eCollection 2017.

34.

Pathological Location of Cranial Nerves in Petroclival Lesions: How to Avoid Their Injury during Anterior Petrosal Approach.

Borghei-Razavi H, Tomio R, Fereshtehnejad SM, Shibao S, Schick U, Toda M, Yoshida K, Kawase T.

J Neurol Surg B Skull Base. 2016 Feb;77(1):6-13. doi: 10.1055/s-0035-1555137. Epub 2015 Jun 19.

35.

Risk factors of Multiple sclerosis and their Relation with Disease Severity: A Cross-sectional Study from Iran.

Abbasi M, Nabavi SM, Fereshtehnejad SM, Ansari I, Zerafatjou N, Shayegannejad V, Mohammadianinejad SE, Farhoudi M, Noorian A, Razazian N, Abedini M, Faraji F.

Arch Iran Med. 2016 Dec;19(12):852-860. doi: 0161912/AIM.007.

36.

Burden of Diarrhea in the Eastern Mediterranean Region, 1990-2013: Findings from the Global Burden of Disease Study 2013.

Khalil I, Colombara DV, Forouzanfar MH, Troeger C, Daoud F, Moradi-Lakeh M, Bcheraoui CE, Rao PC, Afshin A, Charara R, Abate KH, Razek MM, Abd-Allah F, Abu-Elyazeed R, Kiadaliri AA, Akanda AS, Akseer N, Alam K, Alasfoor D, Ali R, AlMazroa MA, Alomari MA, Al-Raddadi RM, Alsharif U, Alsowaidi S, Altirkawi KA, Alvis-Guzman N, Ammar W, Antonio CA, Asayesh H, Asghar RJ, Atique S, Awasthi A, Bacha U, Badawi A, Barac A, Bedi N, Bekele T, Bensenor IM, Betsu BD, Bhutta Z, Abdulhak AA, Butt ZA, Danawi H, Dubey M, Endries AY, Faghmous ID, Farid T, Farvid MS, Farzadfar F, Fereshtehnejad SM, Fischer F, Fitchett JR, Gibney KB, Ginawi IA, Gishu MD, Gugnani HC, Gupta R, Hailu GB, Hamadeh RR, Hamidi S, Harb HL, Hedayati MT, Hsairi M, Husseini A, Jahanmehr N, Javanbakht M, Jibat T, Jonas JB, Kasaeian A, Khader YS, Khan AR, Khan EA, Khan G, Khoja TA, Kinfu Y, Kissoon N, Koyanagi A, Lal A, Latif AA, Lunevicius R, Razek HM, Majeed A, Malekzadeh R, Mehari A, Mekonnen AB, Melaku YA, Memish ZA, Mendoza W, Misganaw A, Mohamed LA, Nachega JB, Nguyen QL, Nisar MI, Peprah EK, Platts-Mills JA, Pourmalek F, Qorbani M, Rafay A, Rahimi-Movaghar V, Rahman SU, Rai RK, Rana SM, Ranabhat CL, Rao SR, Refaat AH, Riddle M, Roshandel G, Ruhago GM, Saleh MM, Sanabria JR, Sawhney M, Sepanlou SG, Setegn T, Sliwa K, Sreeramareddy CT, Sykes BL, Tavakkoli M, Tedla BA, Terkawi AS, Ukwaja K, Uthman OA, Westerman R, Wubshet M, Yenesew MA, Yonemoto N, Younis MZ, Zaidi Z, Zaki ME, Rabeeah AA, Wang H, Naghavi M, Vos T, Lopez AD, Murray CJ, Mokdad AH.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1319-1329. Epub 2016 Oct 10.

37.

Differences in diagnostic process, treatment and social Support for Alzheimer's dementia between primary and specialist care: resultss from the Swedish Dementia Registry.

Garcia-Ptacek S, Modéer IN, Kåreholt I, Fereshtehnejad SM, Farahmand B, Religa D, Eriksdotter M.

Age Ageing. 2017 Mar 1;46(2):314-319. doi: 10.1093/ageing/afw189.

38.

Psychometric properties of the mutuality scale in Swedish dyads with Parkinson's disease.

Karlstedt M, Fereshtehnejad SM, Winnberg E, Aarsland D, Lökk J.

Acta Neurol Scand. 2017 Aug;136(2):122-128. doi: 10.1111/ane.12706. Epub 2016 Oct 26.

PMID:
27781261
39.

Sex differences in stroke: a socioeconomic perspective.

Delbari A, Keyghobadi F, Momtaz YA, Keyghobadi F, Akbari R, Kamranian H, Yazdi MS, Tabatabaei SS, Fereshtehnejad SM.

Clin Interv Aging. 2016 Sep 6;11:1207-1212. eCollection 2016.

40.

Strategies to maintain quality of life among people with Parkinson's disease: what works?

Fereshtehnejad SM.

Neurodegener Dis Manag. 2016 Oct;6(5):399-415. doi: 10.2217/nmt-2016-0020. Epub 2016 Sep 7. Review.

PMID:
27600287
41.

Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry.

Enache D, Fereshtehnejad SM, Kåreholt I, Cermakova P, Garcia-Ptacek S, Johnell K, Religa D, Jelic V, Winblad B, Ballard C, Aarsland D, Fastbom J, Eriksdotter M.

Acta Psychiatr Scand. 2016 Nov;134(5):430-440. doi: 10.1111/acps.12630. Epub 2016 Sep 1.

PMID:
27586958
42.

Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Mokdad AH, Forouzanfar MH, Daoud F, El Bcheraoui C, Moradi-Lakeh M, Khalil I, Afshin A, Tuffaha M, Charara R, Barber RM, Wagner J, Cercy K, Kravitz H, Coates MM, Robinson M, Estep K, Steiner C, Jaber S, Mokdad AA, O'Rourke KF, Chew A, Kim P, El Razek MM, Abdalla S, Abd-Allah F, Abraham JP, Abu-Raddad LJ, Abu-Rmeileh NM, Al-Nehmi AA, Akanda AS, Al Ahmadi H, Al Khabouri MJ, Al Lami FH, Al Rayess ZA, Alasfoor D, AlBuhairan FS, Aldhahri SF, Alghnam S, Alhabib S, Al-Hamad N, Ali R, Ali SD, Alkhateeb M, AlMazroa MA, Alomari MA, Al-Raddadi R, Alsharif U, Al-Sheyab N, Alsowaidi S, Al-Thani M, Altirkawi KA, Amare AT, Amini H, Ammar W, Anwari P, Asayesh H, Asghar R, Assabri AM, Assadi R, Bacha U, Badawi A, Bakfalouni T, Basulaiman MO, Bazargan-Hejazi S, Bedi N, Bhakta AR, Bhutta ZA, Bin Abdulhak AA, Boufous S, Bourne RR, Danawi H, Das J, Deribew A, Ding EL, Durrani AM, Elshrek Y, Ibrahim ME, Eshrati B, Esteghamati A, Faghmous IA, Farzadfar F, Feigl AB, Fereshtehnejad SM, Filip I, Fischer F, Gankpé FG, Ginawi I, Gishu MD, Gupta R, Habash RM, Hafezi-Nejad N, Hamadeh RR, Hamdouni H, Hamidi S, Harb HL, Hassanvand MS, Hedayati MT, Heydarpour P, Hsairi M, Husseini A, Jahanmehr N, Jha V, Jonas JB, Karam NE, Kasaeian A, Kassa NA, Kaul A, Khader Y, Khalifa SE, Khan EA, Khan G, Khoja T, Khosravi A, Kinfu Y, Defo BK, Balaji AL, Lunevicius R, Obermeyer CM, Malekzadeh R, Mansourian M, Marcenes W, Farid HM, Mehari A, Mehio-Sibai A, Memish ZA, Mensah GA, Mohammad KA, Nahas Z, Nasher JT, Nawaz H, Nejjari C, Nisar MI, Omer SB, Parsaeian M, Peprah EK, Pervaiz A, Pourmalek F, Qato DM, Qorbani M, Radfar A, Rafay A, Rahimi K, Rahimi-Movaghar V, Rahman SU, Rai RK, Rana SM, Rao SR, Refaat AH, Resnikoff S, Roshandel G, Saade G, Saeedi MY, Sahraian MA, Saleh S, Sanchez-Riera L, Satpathy M, Sepanlou SG, Setegn T, Shaheen A, Shahraz S, Sheikhbahaei S, Shishani K, Sliwa K, Tavakkoli M, Terkawi AS, Uthman OA, Westerman R, Younis MZ, El Sayed Zaki M, Zannad F, Roth GA, Wang H, Naghavi M, Vos T, Al Rabeeah AA, Lopez AD, Murray CJ.

Lancet Glob Health. 2016 Oct;4(10):e704-13. doi: 10.1016/S2214-109X(16)30168-1. Epub 2016 Aug 25.

43.

Carotid duplex ultrasound and transcranial Doppler findings in commercial divers and pilots.

Dormanesh B, Vosoughi K, Akhoundi FH, Mehrpour M, Fereshtehnejad SM, Esmaeili S, Sabet AS.

Neurol Sci. 2016 Dec;37(12):1911-1916. Epub 2016 Jul 26.

PMID:
27461112
44.

Cerebral microbleeds topography and cerebrospinal fluid biomarkers in cognitive impairment.

Shams S, Granberg T, Martola J, Charidimou A, Li X, Shams M, Fereshtehnejad SM, Cavallin L, Aspelin P, Wiberg-Kristoffersen M, Wahlund LO.

J Cereb Blood Flow Metab. 2017 Mar;37(3):1006-1013. doi: 10.1177/0271678X16649401. Epub 2016 Jul 21.

45.

Assessment and Reporting of Driving Fitness in Patients with Dementia in Clinical Practice: Data from SveDem, the Swedish Dementia Registry.

Lovas J, Fereshtehnejad SM, Cermakova P, Lundberg C, Johansson B, Johansson K, Winblad B, Eriksdotter M, Religa D.

J Alzheimers Dis. 2016 May 5;53(2):631-8. doi: 10.3233/JAD-160254.

46.

Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.

Tajeddinn W, Fereshtehnejad SM, Seed Ahmed M, Yoshitake T, Kehr J, Shahnaz T, Milovanovic M, Behbahani H, Höglund K, Winblad B, Cedazo-Minguez A, Jelic V, Järemo P, Aarsland D.

J Alzheimers Dis. 2016 May 4;53(2):621-30. doi: 10.3233/JAD-160022.

PMID:
27163811
47.

Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers.

Konijnenberg E, Fereshtehnejad SM, Kate MT, Eriksdotter M, Scheltens P, Johannsen P, Waldemar G, Visser PJ.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):146-151. doi: 10.1097/WAD.0000000000000152.

PMID:
27158877
48.

Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases.

Motamed MR, Nasiri F, Fereshtehnejad SM, Mehrpour M, Zamani B, Haghi-Ashtiani B, Rohani F.

Iran J Neurol. 2015 Oct 7;14(4):225-7. No abstract available.

49.

Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment.

Shams S, Granberg T, Martola J, Li X, Shams M, Fereshtehnejad SM, Cavallin L, Aspelin P, Kristoffersen-Wiberg M, Wahlund LO.

J Cereb Blood Flow Metab. 2016 Mar;36(3):621-8. doi: 10.1177/0271678X15606141. Epub 2015 Sep 30.

50.

Mortality in Iranian Patients with Parkinson's Disease: Cumulative Impact of Cardiovascular Comorbidities as One Major Risk Factor.

Fereshtehnejad SM, Shafieesabet A, Shafieesabet M, Shahidi GA, Delbari A, Lökk J.

Parkinsons Dis. 2015;2015:834796. doi: 10.1155/2015/834796. Epub 2015 Oct 20.

Supplemental Content

Loading ...
Support Center